Personalized care plans are crucial because cancer is a highly heterogeneous disease. Each patient’s cancer can have different genetic mutations, biomarkers, and responses to treatment. A one-size-fits-all approach often falls short, leading to suboptimal outcomes. Personalized plans enhance the precision of treatments and can significantly improve survival rates and patient well-being.
